Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
American Journal of Clinical Dermatology
Published in: American Journal of Clinical Dermatology 1/2004

01-02-2004 | Review Article

Management of Acute Sunburn

Authors: Amy Han, Dr Howard I. Maibach

Published in: American Journal of Clinical Dermatology | Issue 1/2004

Login to get access

Abstract

Current literature documents the use of many pharmacologic agents in the management of acute sunburn. While numerous studies have been undertaken, there is no consensus on an algorithm for such treatment. We review the literature for an evidence-based approach to the management of sunburn. A MEDLINE search was conducted whereby all published articles related to sunburn or ultraviolet (UV)-induced erythema from 1966–2001 were evaluated. Studies and reviews were excluded if they were not conducted in human beings. The results of these studies are varying and often conflicting in terms of clinical effectiveness or feasibility. A total of 40 studies were reviewed. Fourteen out of the 40 studies addressed the actual treatment of sunburn (i.e. the application of a substance after the development of signs or symptoms). The majority concluded that either corticosteroids, NSAIDs, antioxidants, antihistamines or emollients were ineffective at decreasing recovery time. The remaining studies showed mild improvement with such treatments, but study designs or methods were flawed. Furthermore, regardless of the treatment modality, the damage to epidermal cells is the same. Given the lack of convincing data and consensus of opinion regarding sunburn management, the most effective and practical approach to acute sunburn is symptomatic treatment of UV light-induced symptoms, including erythema, pain and pruritus.
Literature
1.
Rapaport MJ, Rapaport V. Preventive and therapeutic approaches to short- and long-term sun damaged skin. Clin Dermatol 1998; 16: 429–39PubMedCrossRef
2.
Ferrini RL, Perlman M, Hill L. American college of preventive medicine practice policy statement: skin protection from ultraviolet light exposure. Am J Prev Med 1998; 14: 83–6PubMedCrossRef
3.
Hall HI, May DS, Lew RA, et al. Sun protection behaviors of the US white population. Prev Med 1997; 26: 401–7PubMedCrossRef
4.
Bickers DR. Photosensitivity and other reactions to light. In: Braunwald E, editor. Harrison’s principles of internal medicine. Vol. 15. New York: McGraw-Hill, 2001: 342–8
5.
Hruza L, Pentland A. Mechanisms of UV-induced inflammation. J Invest Dermatol 1993; 100: 35S-41SCrossRef
6.
Walsh L. Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumor necrosis factor-alpha. Immunol Cell Biol 1995; 73: 226–33PubMedCrossRef
7.
Gilchrest B, Soter N, Stoff J, et al. The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol 1981; 5: 411–22PubMedCrossRef
8.
la Ruche G, Cesarini J. Protective effect of oral selenium plus copper associated with vitamin complex on sunburn cell formation in human skin. Photodermatol Photoimmunol Photomed 1991; 8: 232–5PubMed
9.
Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol 1998 Jan; 38: 45–8PubMedCrossRef
10.
Rhodes L, Durham B, Fraser W, et al. Dietary fish oil reduces basal and ultraviolet B generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol 1995; 105: 532–5PubMedCrossRef
11.
Greenwald JS, Parrish JA, Jaenicke KF, et al. Failure of systemically administered corticosteroids to suppress UVB-induced delayed erythema. J Am Acad Dermatol 1981; 5: 197–202PubMedCrossRef
12.
Sukanto H, Nater JP, Bleumink E. Suppression of ultraviolet erythema by topical steroids. Dermatologica 1980; 161: 84–8PubMedCrossRef
13.
Vaananen A, Hannuksela M. UVB erythema inhibited by topically applied substances. Acta Derm Venereol 1989; 69: 12–7PubMed
14.
Morison W, Paul B, Parrish J. The effects of indomethacin on long-wave ultraviolet-induced delayed erythema. J Invest Dermatol 1977; 68: 120–33CrossRef
15.
Edwards Jr E, Horwitz S, Frost P. Reduction of the erythema response to ultraviolet light by nonsteroidal antiinflammatory agents. Arch Dermatol Res 1982; 272: 263–7PubMedCrossRef
16.
Miller W, Ruderman F, Smith Jr J. Aspirin and ultraviolet light-induced erythema in man. Arch Dermatol 1967; 95: 357–8PubMedCrossRef
17.
Anderson T, Peterson C, Hamilton T. Meclofenomate inhibition of UV-induced erythema: a randomized, placebo-controlled, double blind study. Photodermatology 1989; 6: 63–8PubMed
18.
Hughes G, Francom S, Means L, et al. Synergistic effects of oral nonsteroidal drugs and topical corticosteroids in the therapy of sunburn in humans. Dermatology 1992; 184: 54–8PubMedCrossRef
19.
Farr P, Diffey B, Humphreys F. A quantitative study of the effect of terfenadine on cutaneous erythema induced by UVB and UVC radiation. J Invest Dermatol 1986; 87: 771–4PubMedCrossRef
20.
Werninghaus K, Meydani M, Bhawan J, et al. Evaluation of the photoprotective effect of oral Vitamin E supplementation. Arch Dermatol 1994; 130: 1257–61PubMedCrossRef
21.
Gamryn M, Ribaya-Mercado J, Russel R, et al. Effect of beta-carotene supplementation on the human sunburn reaction. Exp Dermatol 1995; 4: 104–11CrossRef
22.
Bangha E, Elsner P, Kistler G. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine): influence of the application time point. Dermatology 1997; 195: 248–52PubMedCrossRef
23.
Schleider NR, Moskowitz RS, Cort DH, et al. Effects of emollients on ultraviolet-radiation-induced erythema of the skin. Arch Dermatol 1979; 115: 1188–91PubMedCrossRef
24.
25.
Hanada K, Sawamura D, Tamai K, et al. Photoprotective effect of esterified glutathione against ultraviolet B-induced sunburn cell formation in hairless mice. J Invest Dermatol 1997; 108: 727–30PubMedCrossRef
26.
Trevithick J, Xiong H, Lee S, et al. Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch Biochem Biophys 1992; 296: 575–82PubMedCrossRef
27.
Stern R, Dodson T. Ibuprofen in the treatment of UV-B-induced inflammation. Arch Dermatol 1985; 121: 508–12PubMedCrossRef
28.
Gomez E, Trancik R. Effect of topical diflumidone on ultraviolet-light-induced erythema. Dermatologica 1981; 163: 175–82CrossRef
29.
Tan P, Flowers F, Araujo O, et al. Effect of topically applied flurbiprofen on ultraviolet-induced erythema. Drug Intell Clin Pharm 1986; 20: 496–9PubMed
30.
Eaglstein W, Ginsberg L, Mertz P. Ultraviolet irradiation-induced inflammation: effects of steroid and nonsteroid anti-inflammatory agents. Arch Dermatol 1979; 115: 1421–3CrossRef
31.
Kaidbey K, Kurban A. The influence of corticosteroids and topical indomethacin on sunburn erythema. J Invest Dermatol 1976; 66: 153–6PubMedCrossRef
32.
Dreher F, Denig N, Gabard B, et al. Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatology 1999; 198: 52–5PubMedCrossRef
33.
Juhlin L, Shroot B. Effect of drugs on early and late phase UV erythema. Acta Derm Venereol 1992; 72: 222–3PubMed
34.
Goldman MS, Leon AJ, Rand GL. Topical and systemic steroids in severe sunburn. Dermatol Int 1966; 5: 75–8PubMedCrossRef
35.
Russo PM, Schneiderman LJ. Effect of topical corticosteroids on symptoms of clinical sunburn. J Fam Pract 1978; 7: 1129–32PubMed
36.
37.
Farr P, Diffey B. A quantitative study of the effect of topical indomethacin on cutaneous erythema induced by UVB and UVC radiation. Br J Dermatol 1986; 115: 453–66PubMedCrossRef
38.
Edwards Jr E, Edwards E. The effect of antihistamines on ultraviolet-light-induced erythema. Int J Dermatol 1983; 22: 540–1PubMedCrossRef
39.
Schaffler K, Beckers C, Unkauf M, et al. Dimethindene maleate in the treatment of sunburn. Arzneimittel Forschung 1999; 49: 374–9PubMed
40.
Moseley H, MacFadyen E, Ferguson M, et al. Reduction of UV-induced erythema in normal subjects by applying methimazole. Photodermatology 1989; 6: 32–6PubMed
41.
Crowell J, Hilsenbeck S, Penneys N. Aloe vera does not affect cutaneous erythema and blood flow following ultraviolet B exposure. Photodermatology 1989; 6: 237–9PubMed
42.
Bangha E, Elsner P, Kistler G. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine): a dose response study. Arch Dermatol Res 1996; 288: 522–6PubMedCrossRef
43.
Driscoll MS, Wagner RF. Clinical management of the acute sunburn. Cutis 2000; 66: 53–8PubMed
Metadata
Title
Management of Acute Sunburn
Authors
Amy Han
Dr Howard I. Maibach
Publication date
01-02-2004
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 1/2004
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200405010-00006

Other articles of this Issue 1/2004

American Journal of Clinical Dermatology 1/2004 Go to the issue

Therapy in Practice

Cutaneous Adverse Effects of Lithium

Images in Dermatopathology

Extensive Angiosarcoma on Chronically Sun-Damaged Skin

EditorialNotes

From the Editor

Original Research Article

The Wrinkle Severity Rating Scale

Guest Commentary

Azelaic Acid

Therapy in Practice

Controlling Scabies in Institutional Settings